Browsing Category
Health
Neuralink competitor Synchron buys fairness stake in producer
Philip O'Keefe, one of Synchron's patients in the SWITCH clinical trial, was the first person in the world to tweet using a BCI device.Source: SynchronNeurotech…
Merck (MRK) This autumn earnings report 2023
The logo for Merck & Co. is displayed on a screen at the New York Stock Exchange (NYSE) in New York City, New York, U.S., November 17, 2021. Andrew Kelly |…
This autumn earnings shaping as much as be one of the best of 2023
Traders work on the floor at the New York Stock Exchange on Feb. 1, 2024.Brendan McDermid | ReutersHere's how big of a surprise corporate profits have been this…
Bristol Myers Squibb (BMY) This autumn earnings report 2023
Bristol Myers Squibb reported quarterly earnings and revenue that topped expectations on Friday as its portfolio of new drugs posted strong sales growth. Here's…
Advert big Publicis paying $350 million to settle U.S. opioid claims
A sign for Publicis Groupe SA is seen at their headquarters in Paris, France, on Sunday, July 28, 2013. Balint Porneczi | Bloomberg | Getty ImagesThe healthcare…
We’re trimming a health-care inventory forward of earnings — hedging our bets on enterprise in…
We're selling 95 shares of GE Healthcare at roughly $74. Following Wednesday's trade, Jim Cramer's Charitable Trust will own 1,150 shares of GEHC, reducing its…
Vertex non-opioid painkiller exhibits constructive late-stage trial outcomes
A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston on Oct. 23, 2019.Brian Snyder | ReutersVertex Pharmaceuticals on Tuesday…
Elon Musk’s Neuralink implants mind tech in human affected person for the primary time
Jonathan Raa | Nurphoto | Getty ImagesElon Musk's neurotech startup Neuralink implanted its device in a human for the first time on Sunday, and the patient is…
Huge pharma Merck, Bristol Myers, J&J put together to lose income
The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium. NYSEBig pharmaceutical companies such as Bristol Myers Squibb, Merck and…
Merck, J&J CEOs conform to testify in Senate listening to on drug costs
Sen. Bernie Sanders, I-Vt., holds his news conference with Sen. Ed Markey, D-Mass., in the Capitol on Thursday, January 25, 2024, on issuing subpoenas for…